<DOC>
	<DOC>NCT02902094</DOC>
	<brief_summary>DeVA is a single blinded, prospective, multicentre RCT designed to determine the safety and effectiveness of a drug eluting angioplasty balloon compared with a standard angioplasty balloon in patients with symptomatic native AV fistula stenosis.</brief_summary>
	<brief_title>Drug Eluting Balloon Venoplasty in AV Fistula Stenosis</brief_title>
	<detailed_description />
	<mesh_term>Constriction, Pathologic</mesh_term>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Arteriovenous Fistula</mesh_term>
	<criteria>Arteriovenous (AV) fistulas with stenosis requiring percutaneous angioplasty identified on routine diagnostic imaging or causing clinical concern on dialysis. Fistula has been in use for at least 1 month and is &gt; 6 weeks old Brachiocephalic AV fistula Brachiobasilic AV fistula Radiocephalic AV fistula (both proximal and distal) Participant &gt;/=18 yrs old Index lesion is less then the length of the DEB, and the reference vessel diameter is appropriate for treatment with the size range of DEB (4mm 8mm diameter) Participant is able to give valid informed consent Allergy to iodinated Intravenous contrast Allergy to Paclitaxel Prosthetic grafts Long or tandem lesions that cannot be treated with a single DEB Thrombosed ArterioVenous fistulas Women who are breastfeeding, pregnant or intending to become pregnant Participants of childbearing age who are unwilling to use a reliable form of contraception for the duration of the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>